W J VandenHeuvel

Title: W J VandenHeuvel: Innovator in Pharmaceutical Formulations

Introduction

W J VandenHeuvel is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as testosterone 5.alpha.-reductase inhibitors. His work has implications for treating various medical conditions, including acne and benign prostatic hypertrophy.

Latest Patents

W J VandenHeuvel holds a patent for oxidized analogs of specific compounds. The patent details compounds of the formula (I) wherein R is selected from hydrogen, methyl, or ethyl, and R.sup.1 is a C.sub.1-12 straight or branched chain alkyl. One of the hydrogens in R.sup.1 is substituted by hydroxy, carboxylic acid, or C.sub.1-4 alkyl ester. The compounds are noted for their pharmaceutical formulations that are active as testosterone 5.alpha.-reductase inhibitors.

Career Highlights

W J VandenHeuvel is associated with Merck & Co., Inc., a leading pharmaceutical company. His work at Merck has allowed him to focus on innovative solutions in drug development. He has been instrumental in advancing formulations that address significant health issues.

Collaborations

W J VandenHeuvel has collaborated with notable colleagues, including Gary H Rasmusson and Josephine R Carlin. These collaborations have contributed to the successful development of his patented compounds.

Conclusion

W J VandenHeuvel's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.